Priority Topics and Scope

The International Journal of Thorax invites submissions that advance thoracic and respiratory medicine across clinical, translational, and population health domains.

We welcome studies in pulmonology, thoracic surgery, critical care, sleep medicine, and thoracic imaging.

Priority topics include COPD, asthma, interstitial lung disease, pulmonary hypertension, and respiratory infections such as tuberculosis and viral pneumonia.

Oncology focused work on lung cancer screening, staging, surgical approaches, radiotherapy, and systemic therapy outcomes is encouraged.

Transplantation, pleural disease, chest wall disorders, and minimally invasive thoracic procedures are within scope.

We value rigorous clinical trials, observational cohorts, registry analyses, and real world evidence with clearly defined methods and outcomes.

Diagnostic innovations in bronchoscopy, endobronchial ultrasound, imaging, and pulmonary function testing are welcome.

Translational studies on biomarkers, omics, and precision medicine are encouraged when linked to clinical relevance.

Research on ventilation strategies, ARDS, ICU management, and pulmonary rehabilitation is highly relevant.

Environmental and occupational lung disease, smoking cessation, and public health interventions are considered.

Systematic reviews and meta analyses are welcome when protocols and reporting standards are followed.

All submissions should include clear data availability, ethics approvals, and trial registration when applicable.

We welcome submissions on COPD, asthma, and chronic bronchitis management.

Research on interstitial lung disease and pulmonary fibrosis is within scope.

Pulmonary hypertension, vascular disease, and right heart interactions are encouraged.

Lung cancer screening, staging, and outcomes research are prioritized.

Thoracic surgery innovations, minimally invasive techniques, and postoperative outcomes are welcome.

Critical care topics such as ARDS, ventilation strategies, and ECMO are highly relevant.

Respiratory infections including tuberculosis, pneumonia, and emerging pathogens are in scope.

Sleep medicine and sleep disordered breathing studies are encouraged.

Pulmonary rehabilitation and quality of life outcomes research is welcome.

Occupational and environmental lung disease and smoking cessation interventions are relevant.

Transplantation research including donor management and long term outcomes is encouraged.

Bronchoscopy, endobronchial ultrasound, and interventional pulmonology studies are welcome.

Imaging innovations in CT, MRI, ultrasound, and AI assisted diagnostics are within scope.

Biomarker, omics, and precision medicine studies with clinical relevance are encouraged.